메뉴 건너뛰기




Volumn 34, Issue 3, 2007, Pages 588-591

Mycophenolate mofetil and intravenous dexamethasone in the treatment of persistent lupus myelitis

Author keywords

Dexamethasone; Mycophenolate mofetil; Systemic lupus erythematosus; Transverse myelitis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NADROPARIN; PREDNISONE;

EID: 33847685868     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (18)

References (15)
  • 1
    • 20144387997 scopus 로고    scopus 로고
    • Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
    • Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005;64:620-5.
    • (2005) Ann Rheum Dis , vol.64 , pp. 620-625
    • Barile-Fabris, L.1    Ariza-Andraca, R.2    Olguin-Ortega, L.3
  • 2
    • 0034108670 scopus 로고    scopus 로고
    • Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature
    • Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-4.
    • (2000) Ann Rheum Dis , vol.59 , pp. 120-124
    • Kovacs, B.1    Lafferty, T.L.2    Brent, L.H.3    DeHoratius, R.J.4
  • 3
    • 0742305109 scopus 로고    scopus 로고
    • Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: Good functional outcome and relevance of antiphospholipid antibodies
    • D'Cruz DP, Mellor-Pita S, Joven B, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 2004;31:280-5.
    • (2004) J Rheumatol , vol.31 , pp. 280-285
    • D'Cruz, D.P.1    Mellor-Pita, S.2    Joven, B.3
  • 4
    • 0035660372 scopus 로고    scopus 로고
    • Longitudinal myelitis associated with systemic lupus erythematosus: Clinical features and magnetic resonance imaging of six cases
    • Tellez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Davila-Maldonado L. Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus 2001;10:851-6.
    • (2001) Lupus , vol.10 , pp. 851-856
    • Tellez-Zenteno, J.F.1    Remes-Troche, J.M.2    Negrete-Pulido, R.O.3    Davila-Maldonado, L.4
  • 5
    • 1242272184 scopus 로고    scopus 로고
    • Longitudinal myelitis as an initial manifestation of systemic lupus erythematosus
    • Chen HC, Lai JH, Kuo SY, Chen CH, Chang DM. Longitudinal myelitis as an initial manifestation of systemic lupus erythematosus. Am J Med Sci 2004;327:105-8.
    • (2004) Am J Med Sci , vol.327 , pp. 105-108
    • Chen, H.C.1    Lai, J.H.2    Kuo, S.Y.3    Chen, C.H.4    Chang, D.M.5
  • 6
    • 0036068984 scopus 로고    scopus 로고
    • Transverse myelitis in patients with antiphospholipid antibodies: The importance of early diagnosis and treatment
    • Sherer Y, Hassin S, Shoenfeld Y, et al. Transverse myelitis in patients with antiphospholipid antibodies: the importance of early diagnosis and treatment. Clin Rheumatol 2002;21:207-10.
    • (2002) Clin Rheumatol , vol.21 , pp. 207-210
    • Sherer, Y.1    Hassin, S.2    Shoenfeld, Y.3
  • 7
    • 0036119184 scopus 로고    scopus 로고
    • Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord
    • Kimura KY, Seino Y, Hirayama Y, et al. Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord. Intern Med 2002;41:156-60.
    • (2002) Intern Med , vol.41 , pp. 156-160
    • Kimura, K.Y.1    Seino, Y.2    Hirayama, Y.3
  • 8
    • 0034062107 scopus 로고    scopus 로고
    • Involvement of the entire spinal cord and medulla oblongata in acute catastrophic-onset transverse myelitis in SLE
    • Neumann-Andersen G, Lindgren S. Involvement of the entire spinal cord and medulla oblongata in acute catastrophic-onset transverse myelitis in SLE. Clin Rheumatol 2000;19:156-60.
    • (2000) Clin Rheumatol , vol.19 , pp. 156-160
    • Neumann-Andersen, G.1    Lindgren, S.2
  • 9
    • 0345306156 scopus 로고    scopus 로고
    • Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus
    • Campos LM, Kiss MH, D'Amico EA, Silva CA. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 2003;12:820-6.
    • (2003) Lupus , vol.12 , pp. 820-826
    • Campos, L.M.1    Kiss, M.H.2    D'Amico, E.A.3    Silva, C.A.4
  • 10
    • 0034935149 scopus 로고    scopus 로고
    • Mycophenolate-mofetil in the treatment of refractory multiple sclerosis
    • Ahrens N, Salama A, Haas J. Mycophenolate-mofetil in the treatment of refractory multiple sclerosis. J Neurol 2001;248:713-4.
    • (2001) J Neurol , vol.248 , pp. 713-714
    • Ahrens, N.1    Salama, A.2    Haas, J.3
  • 11
    • 0036051895 scopus 로고    scopus 로고
    • Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents
    • Karim MY, Alba P, Cuadrado MJ, et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology Oxford 2002;41:876-82.
    • (2002) Rheumatology Oxford , vol.41 , pp. 876-882
    • Karim, M.Y.1    Alba, P.2    Cuadrado, M.J.3
  • 12
    • 0346705425 scopus 로고    scopus 로고
    • Central nervous system involvement due to systemic lupus erythematosus/antiphospholipid syndrome: Successful treatment with mycophenolate mofetil
    • Grisanti M, Nader A, Caciuttolo R. Central nervous system involvement due to systemic lupus erythematosus/antiphospholipid syndrome: successful treatment with mycophenolate mofetil. Lupus 2001;10:S31.
    • (2001) Lupus , vol.10
    • Grisanti, M.1    Nader, A.2    Caciuttolo, R.3
  • 13
    • 24344503763 scopus 로고    scopus 로고
    • Mycophenolate mofetil in neuropsychiatric lupus erythematosus
    • Jose J, Paulose BK, Vasuki Z, Danda D. Mycophenolate mofetil in neuropsychiatric lupus erythematosus. Indian J Med Sci 2005;59:353-6.
    • (2005) Indian J Med Sci , vol.59 , pp. 353-356
    • Jose, J.1    Paulose, B.K.2    Vasuki, Z.3    Danda, D.4
  • 14
    • 1242314352 scopus 로고    scopus 로고
    • Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus
    • Lhotta K, Wurzner R, Rosenkranz AR, et al. Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus. Lupus 2004;13:139-41.
    • (2004) Lupus , vol.13 , pp. 139-141
    • Lhotta, K.1    Wurzner, R.2    Rosenkranz, A.R.3
  • 15
    • 0031982733 scopus 로고    scopus 로고
    • Refractory hiccough heralding transverse myelitis in the primary antiphospholipid syndrome
    • Ruiz-Arguelles GJ, Guzman-Ramos J, Flores-Flores J, Garay-Martinez J. Refractory hiccough heralding transverse myelitis in the primary antiphospholipid syndrome. Lupus 1998;7:49-50.
    • (1998) Lupus , vol.7 , pp. 49-50
    • Ruiz-Arguelles, G.J.1    Guzman-Ramos, J.2    Flores-Flores, J.3    Garay-Martinez, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.